Advances in immuno-based and targeted therapies in extensive-stage small cell lung cancer

Advances in immuno-based and targeted therapies in extensive-stage small cell lung cancer

Immunotherapy now plays a key role in supplementing and even replacing conventional agents in tumor treatment. Immune checkpoint inhibitors (ICIs), represented by atezolizumab and durvalumab, have shown encouraging therapeutic effects in the combination chemotherapy for extensive-stage small cell lu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiao-Tong Zou, Jie Huang, Hao Sun, Li-Na Chen, Xiu-Hao Zhang, Jin-Ji Yang
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-07-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359251359057
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in Radiotherapy for Extensive-stage Small Cell Lung Cancer  in the Era of Immunotherapy
by: Tingting CHEN, et al.
Published: (2025-05-01)

Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
by: Ayako Nawashiro, et al.
Published: (2022-01-01)

Advances of Neoadjuvant Targeted Therapy in ALK-positive Non-small Cell Lung Cancer
by: Weizhen SUN, et al.
Published: (2024-11-01)

Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy
by: Wenxin Ding, et al.
Published: (2025-06-01)

Cost-effectiveness analysis of Toripalimab regimen for extensive-stage small-cell lung cancer in China and America
by: Jing Yang, et al.
Published: (2025-05-01)

Anti-PGK1 antibodies in immuno-related pancytopenia
by: Shanfeng Hao, et al.
Published: (2025-12-01)

Factors affecting survival and prognosis in extensive stage small cell lung cancer
by: Mert Erciyestepe, et al.
Published: (2025-04-01)

REGIONAL IMMUNO- AND NO – THERAPY IN COMPEX TREATMENT OF EPITHELIAL COCCYGEAL WAY IN ABSCESS STAGE
by: M. A. TOPCHIEV, et al.
Published: (2017-05-01)

Evaluating the safety and efficacy of combination immune checkpoint inhibitors and chemotherapy treatment in extensive-stage small cell lung cancer
by: Yalin Xie, et al.
Published: (2025-05-01)

Systemic Chemotherapy for Progression of Brain Metastases in Extensive-Stage Small Cell Lung Cancer
by: Nagla Abdel Karim, et al.
Published: (2015-01-01)

Immunotherapy for Extensive-stage Small Cell Lung Cancer:  Research Progress and Future Perspectives
by: Yuling ZHONG, et al.
Published: (2024-11-01)

Multidimensional comparative evaluation of first-line therapies for extensive-stage small cell lung cancer: a systematic review and network meta-analysis of clinical efficacy and safety profiles
by: Ziyao Jiang, et al.
Published: (2025-08-01)

Cost-effectiveness of benmelstobart and anlotinib plus chemotherapy as first-line therapy for extensive-stage small cell lung cancer in China
by: Chunyan Yan, et al.
Published: (2025-03-01)

Consolidative thoracic radiotherapy improves the prognosis of extensive stage small-cell lung cancer patients in the chemoimmunotherapy era: a multicenter retrospective analysis
by: Nan Yao, et al.
Published: (2025-12-01)

The Optimal First‐Line Therapy for Extensive‐Stage Small‐Cell Lung Cancer Based on Liver Metastasis Status: A Network Meta‐Analysis and Systematic Review
by: Shu‐Ling Zhang, et al.
Published: (2024-09-01)

Radiotherapy Combined with Immunotherapy and Chemotherapy Improves Prognosis and Demonstrates Synergistic Effects in Extensive-stage Small Cell Lung Cancer
by: Huaijun JI, et al.
Published: (2024-11-01)

Cost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer
by: Maojin You, et al.
Published: (2024-11-01)

Multifunctional Biomimetic Nanocarriers for Dual‐Targeted Immuno‐Gene Therapy Against Hepatocellular Carcinoma
by: Yupeng Sun, et al.
Published: (2024-09-01)

Cost-effectiveness evaluation of benmelstobart, anlotinib and chemotherapy in patients with extensive-stage small-cell lung cancer
by: Jing Nie, et al.
Published: (2025-08-01)

Prognostic value of pretreatment procalcitonin and neutrophil–lymphocyte ratio in extensive-stage small-cell lung cancer
by: Dongfang Chen, et al.
Published: (2024-12-01)

Adjuvant therapy with immuno-modulators în oncology
by: Ioana Chitescu, et al.
Published: (2019-05-01)

Toripalimab plus chemotherapy versus chemotherapy as first-line therapy for extensive-stage small cell lung cancer: a cost-effectiveness analysis
by: Longfeng Zhang, et al.
Published: (2025-07-01)

Cost-effectiveness analysis of anlotinib plus chemotherapy with or without benmelstobart versus chemotherapy alone for extensive-stage small-cell lung cancer in China
by: Caicong You, et al.
Published: (2024-12-01)

Single-cell RNA sequencing reveals cellular and molecular heterogeneity in extensive-stage small cell lung cancer with different chemotherapy responses
by: Zhan Gu, et al.
Published: (2025-04-01)

Development of a prognostic model for patients with extensive-stage small cell lung cancer undergoing immunotherapy and chemotherapy
by: Yunbin Gao, et al.
Published: (2025-03-01)

Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer
by: Ke Zhao, et al.
Published: (2025-03-01)

First-line durvalumab plus platinum–etoposide in Japanese patients with extensive-stage small-cell lung cancer
by: Eisuke Mochizuki, et al.
Published: (2025-01-01)

Machine learning-based prediction model for brain metastasis in patients with extensive-stage small cell lung cancer
by: Erha Munai, et al.
Published: (2024-11-01)

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for extensive-stage small cell lung cancer from the perspective of the healthcare system in China
by: Feng Chen, et al.
Published: (2025-05-01)

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
by: Anna De Lucia, et al.
Published: (2025-02-01)

Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.
by: Xiaofeng Chen, et al.
Published: (2013-01-01)

Immunotherapy in Early and Locally Advanced Stage Non-small Cell Lung Cancer
by: Abdülkadir Koçanoğlu, et al.
Published: (2025-04-01)

Perspectives from the leadership of Journal for ImmunoTherapy of Cancer
by: Sjoerd H van der Burg, et al.
Published: (2024-06-01)

Integration of intratumoral and peritumoral CT radiomic features with machine learning algorithms for predicting induction therapy response in locally advanced non-small cell lung cancer
by: FangHao Cai, et al.
Published: (2025-03-01)

The combination of chemotherapy and immune checkpoint inhibitors in recurrent extensive-stage small cell lung cancer: a case report
by: Chunxiu Hu, et al.
Published: (2025-07-01)

Durvalumab-induced organizing pneumonia in extensive-stage small cell lung cancer: A case report and literature review
by: Guoxin Wang, MD, et al.
Published: (2025-05-01)

First-line chemotherapy with tislelizumab for patients with extensive-stage small cell lung cancer: a cost-effectiveness analysis
by: Rong Long, et al.
Published: (2024-12-01)

Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer.
by: Zhiwei Zheng, et al.
Published: (2025-01-01)

Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer
by: Zhiwei Zheng, et al.
Published: (2025-01-01)

The role of radiotherapy in extensive-stage small cell lung cancer: insights from treatment failure patterns in the era of immunotherapy
by: Ya Zhang, et al.
Published: (2024-12-01)